Drugs / Dust mite drops
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT05570383 | Dec 2022 → Dec 2023 | allergic rhinitis | People's Hospital of Anshun City of Guizhou Province | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dust mite drops | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05570383 ↗ |
| Known as | Changdi | “Dust mite drops (trade name: Changdi, Zhejiang Tawu Biotechnology Co. Ltd.).” NCT05570383 ↗ |
| Modality | Vaccine | “The allergen vaccine of SLIT is mainly dust mite drops in China.” NCT05570383 ↗ |